ADC Therapeutics SA (ADCT) financials · rev $81.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
ADC Therapeutics SA (ADCT) rev $81.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $81.4M | $70.8M |
| Cost of Revenue | $5.80M | $5.95M |
| Gross Profit | $75.6M | $64.9M |
| Operating Income | -$121.5M | -$130.7M |
| Net Income | -$142.6M | -$157.8M |
| EPS (Diluted) | -$1.12 | -$1.62 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $323.1M | $322.0M |
| Current Assets | $306.3M | $307.4M |
| Cash & Equivalents | $261.3M | $250.9M |
| Inventory | $4.18M | $18.4M |
| PP&E | N/A | $5.08M |
| Total Liabilities | $509.0M | $524.6M |
| Current Liabilities | $70.2M | $80.5M |
| Short-term Debt | $3.00M | N/A |
| Total Debt | $3.00M† | N/A |
| Shareholders' Equity | -$185.8M | -$202.6M |
| Retained Earnings | -$1.64B | -$1.49B |
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$141.2M | -$123.8M |
| CapEx | $264.0K | $867.0K |
| Investing Cash Flow | $395.0K | -$867.0K |
| Financing Cash Flow | $150.9M | $97.1M |
| Free Cash Flow | -$141.4M | -$124.7M |
FAQ
What is ADCT P/E and revenue?
ADC Therapeutics SA (ADCT) rev $81.4M.
What is ADCT revenue?
ADC Therapeutics SA last cached revenue is $81.4M (FY2025).
Is ADCT profitable?
ADC Therapeutics SA last cached net income is -$142.6M (FY2025).
What are ADCT total assets?
ADC Therapeutics SA last cached total assets are $323.1M (FY2025).
What is ADCT free cash flow?
ADC Therapeutics SA last cached free cash flow is -$141.4M (FY2025).
Not investment advice. Cached statements, not a live tape.